GLP-1 medications run between $617 and $766 per month at list price and when large employers began covering them at scale, the impact on pharmacy benefit spending was immediate and significant. The numbers tell the story clearly
Drug Shortages: Semaglutide Injection
This article explores the current science, clinical implications, and how to have informed, practical conversations with patients without overpromising results
Key differences at a glance Understanding GLP-1 medications GLP-1 (glucagon-like peptide-1) receptor agonists were originally developed for type 2 diabetes but have revolutionised obesity treatment
Individuals should be counseled to avoid refined carbohydrates (i.e., refined grains, flour, starches, sugars), sugar-sweetened beverages, red and processed meats, and most fast foods, ultra-processed sweets, and savory snacks (Table 6)
The drug, which belongs to GLP-1 medications, appears to dramatically reduce both alcohol cravings and drinking behavior